Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Rituxan rituximab: Phase II data; marketed to treat low-grade NHL

Phase II testing of Rituxan in combination with chemotherapy showed that the combination produced a 100

Read the full 166 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE